Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 8 studies | 58% ± 21% | |
epithelial cell of proximal tubule | 5 studies | 47% ± 17% | |
epithelial cell | 5 studies | 39% ± 26% | |
intestinal crypt stem cell | 3 studies | 36% ± 5% | |
progenitor cell | 3 studies | 38% ± 22% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 4 studies | 31% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 9523.16 | 226 / 226 | 87% | 9.84 | 353 / 406 |
intestine | 74% | 3243.28 | 711 / 966 | 68% | 4.65 | 357 / 527 |
kidney | 100% | 3394.31 | 89 / 89 | 26% | 0.69 | 237 / 901 |
ovary | 78% | 26.61 | 141 / 180 | 9% | 0.16 | 37 / 430 |
stomach | 13% | 5.17 | 47 / 359 | 67% | 4.78 | 193 / 286 |
spleen | 73% | 28.17 | 177 / 241 | 0% | 0 | 0 / 0 |
bladder | 43% | 12.81 | 9 / 21 | 27% | 1.88 | 136 / 504 |
lung | 46% | 11.41 | 263 / 578 | 9% | 0.50 | 99 / 1155 |
breast | 53% | 20.07 | 244 / 459 | 0% | 0.00 | 4 / 1118 |
prostate | 51% | 12.95 | 124 / 245 | 0% | 0.01 | 2 / 502 |
uterus | 41% | 11.80 | 69 / 170 | 3% | 0.07 | 13 / 459 |
brain | 41% | 14.87 | 1094 / 2642 | 1% | 0.01 | 5 / 705 |
adipose | 42% | 14.28 | 502 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 16% | 7.33 | 236 / 1445 | 25% | 1.12 | 45 / 183 |
skin | 27% | 7.41 | 492 / 1809 | 0% | 0.01 | 2 / 472 |
thymus | 26% | 6.20 | 171 / 653 | 1% | 0.02 | 4 / 605 |
blood vessel | 25% | 6.77 | 335 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 21% | 26.14 | 199 / 929 | 0% | 0 | 0 / 0 |
pancreas | 5% | 0.93 | 15 / 328 | 13% | 0.26 | 23 / 178 |
adrenal gland | 16% | 4.11 | 41 / 258 | 0% | 0.02 | 1 / 230 |
heart | 10% | 2.37 | 90 / 861 | 0% | 0 | 0 / 0 |
muscle | 3% | 0.57 | 21 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006974 | Biological process | DNA damage response |
GO_2001140 | Biological process | positive regulation of phospholipid transport |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0071481 | Biological process | cellular response to X-ray |
GO_1905885 | Biological process | positive regulation of triglyceride transport |
GO_1902426 | Biological process | deactivation of mitotic spindle assembly checkpoint |
GO_0006977 | Biological process | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
GO_1904731 | Biological process | positive regulation of intestinal lipid absorption |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005576 | Cellular component | extracellular region |
GO_0017129 | Molecular function | triglyceride binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PRAP1 |
Protein name | Proline-rich acidic protein 1 (Epididymis tissue protein Li 178) (Uterine-specific proline-rich acidic protein) |
Synonyms | UNQ608/PRO1195 UPA |
Description | FUNCTION: Lipid-binding protein which promotes lipid absorption by facilitating MTTP-mediated lipid transfer (mainly triglycerides and phospholipids) and MTTP-mediated apoB lipoprotein assembly and secretion (By similarity). Protects the gastrointestinal epithelium from irradiation-induced apoptosis (By similarity). May play an important role in maintaining normal growth homeostasis in epithelial cells . Involved in p53/TP53-dependent cell survival after DNA damage . May down-regulate the expression of MAD1L1 and exert a suppressive role in mitotic spindle assembly checkpoint in hepatocellular carcinomas . . |
Accessions | ENST00000463201.2 [Q96NZ9-4] Q96NZ9 ENST00000433452.6 [Q96NZ9-1] |